Skip to main content

Advertisement

Log in

Trend of eGFR in an Italian cohort of mother-to-child HIV-infected patients exposed to tenofovir for at least 2 years

  • Short Communication
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

Abstract

The aim of this study is to describe longitudinal changes in estimated glomerular filtration rate (eGFR) in a cohort of mother-to-child HIV-infected adolescents exposed to tenofovir dixoproxil fumarate (TDF) for at least 2 years. We retrospectively examined eGFR at starting TDF (T0), at 24 months (T2) and at the final assessment (T3). Twenty-nine patients were studied. The mean duration of TDF exposure was 67 months (24–123). At baseline, the mean eGFR was 152 ml/min/1.73 m2 (105–227, SD, 33). There was a significant decrease of eGFR from a mean of 152 ml/min/1.73 m2 (SD, 33) at T0 to 140 ml/min/1.73 m2 (SD, 33) at T2 and 123 ml/min/1.73 m2 (SD, 14) at T3. The decrease of eGFR was significant, with ΔGFR (T3-T0) of −29 ml/min/1.73 m2 (SD, 30; p < 0.0001) and a mean ΔGFR per year of −6 and ml/min/1.73 m2 (SD, 8).

Conclusion: We noted a long-term decline in eGFR in this small cohort of mother-to-child HIV-infected adolescents receiving TDF-containing cART, even if the lack of a control group and the small sample size are major limitations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Abbreviations

cART:

Combined antiretroviral therapy

eGFR:

Estimated glomerular filtration rate

HBV:

Hepatitis B virus

HCV:

Hepatitis C virus

PI:

Protease inhibitor

TDF:

Tenofovir dixoproxil fumarate

References

  1. Cooper RD, Wiebe N, Smith N, Keiser P, Naicker S, Tonelli M (2010) Systematic review and meta-analysis: renal safety of tenofovir disoproxil fumarate in HIV-infected patients. Clin Infect Dis 51:496–505

    Article  CAS  PubMed  Google Scholar 

  2. Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. Department of Health and Human Service 2014. Available at http://aidsinfo.nih.gov/contentfiles/lvguidelines/AdultandAdolescentGL.pdf. (Accessed on: 15 Jun 2014)

  3. Hall AM (2013) Update on tenofovir toxicity in the kidney. Pediatr Nephrol 28:1011–1023

    Article  PubMed  Google Scholar 

  4. Judd A, Boyd KL, Stöhr W, Dunn D, Butler K, Lyall H, Sharland M, Shingadia D, Riordan A, Gibb DM (2010) Effect of tenofovir disoproxil fumarate on risk of renal abnormality in HIV-1-infected children on antiretroviral therapy: a nested case–control study. AIDS 24:525–534

    Article  CAS  PubMed  Google Scholar 

  5. Laprise C, Baril JG, Dufresne S, Trottier H (2013) Association between tenofovir exposure and reduced kidney function in a cohort of HIV-positive patients: results from 10 years of follow-up. CID 56:567–575

    Article  Google Scholar 

  6. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J, CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604–612

    Article  PubMed Central  PubMed  Google Scholar 

  7. Pontrelli G, Cotugno N, Amodio D, Zangari P, Tchidjou HK, Baldassari S, Palma P, Bernardi S (2012) Renal function in HIV-infected children and adolescents treated with tenofovir disoproxil fumarate and protease inhibitors. BMC Infect Dis 12:18

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  8. Riordan A, Judd A, Boyd K, Cliff D, Doerholt K, Lyall H, Menson E, Butler K, Gibb D, Collaborative HIV Paediatric Study (2009) Tenofovir use in human immunodeficiency virus-1-infected children in the United Kingdom and Ireland. Pediatr Infect Dis J 28(3):204–209

    Article  PubMed  Google Scholar 

  9. Röling J, Schmid H, Fischereder M, Draenert R, Goebel FD (2006) HIV-associated renal diseases and highly active antiretroviral therapy-induced nephropathy. Clin Infect Dis 42:1488–1495

    Article  PubMed  Google Scholar 

  10. Schwartz GJ, Gauthier B (1985) A simple estimate of glomerular filtration rate in adolescent boys. J Pediatr 106:522–526

    Article  CAS  PubMed  Google Scholar 

  11. Viganò A, Bedogni G, Manfredini V, Giacomet V, Cerini C, di Nello F, Penagini F, Caprio C, Zuccotti GV (2011) Long-term renal safety of tenofovir disoproxil fumarate in vertically HIV-infected children, adolescents and young adults: a 60-month follow-up study. Clin Drug Investig 31:407–415

    Article  PubMed  Google Scholar 

  12. Viread: new formulation, and pediatric dosing update. http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm294434.htm

Download references

Aknowledgments

Dr. Raffaella Rosso passed away during the development of this manuscript. She first had the idea to start this work and collect data.

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Paola Tatarelli.

Additional information

Communicated by David Nadal

Revisions received: 10 October 2014/17 November 2014/25 November 2014

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Grignolo, S., Tatarelli, P., Gustinetti, G. et al. Trend of eGFR in an Italian cohort of mother-to-child HIV-infected patients exposed to tenofovir for at least 2 years. Eur J Pediatr 174, 843–846 (2015). https://doi.org/10.1007/s00431-014-2468-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00431-014-2468-2

Keywords

Navigation